Zhu, G.* et al. Autoinflammatory encephalopathy due to PTPN1 haploinsufficiency: A case series. Lancet Neurol. 24, 218-229 (2025)
GBD 2021 Stroke Risk Factor Collaborators (Breitner-Busch, S.) Global, regional, and national burden of stroke and its risk factors, 1990-2021: A systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 23, 973-1003 (2024)
Morenas-Rodríguez, E.* et al. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: A longitudinal observational study. Lancet Neurol. 21, 329-341 (2022)
Miglis, M.G.* et al. Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder. Lancet Neurol. 20, 671-684 (2021)
Zech, M. et al. Monogenic variants in dystonia: An exome-wide sequencing study. Lancet Neurol. 19, 908-918 (2020)
Pottier, C.* et al. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: A genome-wide association study. Lancet Neurol. 17, 548-558 (2018)
Trenkwalder, C.* et al. Comorbidities, treatment, and pathophysiology in restless legs syndrome. Lancet Neurol. 17, 994-1005 (2018)
Moss, D.J.H.* et al. Identification of genetic variants associated with Huntington's disease progression: A genome-wide association study. Lancet Neurol. 16, 701-711 (2017)
Schormair, B. et al. Identification of novel risk loci for restless legs syndrome: A meta-analysis of genome-wide association studies in individuals of European ancestry: A meta-analysis. Lancet Neurol. 16, 898–907 (2017)
Mok, K.Y.* et al. Deletions at 22q11.2 in idiopathic Parkinson's disease: A combined analysis of genome-wide association data. Lancet Neurol. 15, 585-596 (2016)
International Stroke Genetics Consortium (Pulit, S.L.* ; McArdle, P.F.* ; Wong, Q.* ; Malik, R.* ; Gieger, C. ; Meisinger, C. ; Müller-Nurasyid, M. ; Peters, A. ; Strauch, K. ; Waldenberger, M. ; Rosand, J.*) Loci associated with ischaemic stroke and its subtypes (SiGN): A genome-wide association study. Lancet Neurol. 15, 174-184 (2016)
Jansen, I.E.* et al. CHCHD2 and Parkinson's disease. Lancet Neurol. 14, 678-679 (2015)
International League Against Epilepsy Consortium on Complex Epilepsies (Gieger, C. ; Grallert, H. ; Heinrich, J. ; Holle, R. ; Leidl, R. ; Meisinger, C. ; Peters, A. ; Strauch, K.) Genetic determinants of common epilepsies: A meta-analysis of genome-wide association studies. Lancet Neurol. 13, 893-903 (2014)
Trenkwalder, C.* et al. Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: A double-blind, randomised, placebo-controlled trial with an open-label extension. Lancet Neurol. 12, 1141-1150 (2013)
Kretzschmar, H.* & Illig, T. Are further genetic factors associated with the risk of developing variant Creutzfeldt-Jakob disease? Lancet Neurol. 8, 25-26 (2009)